Equillium reports Q2 2026 results, plans Australia dossier filing for EQ504
The company said it expects to start a Phase 1 study of EQ504 in the fourth quarter of 2026, with topline data about six months later, while cash on hand is projected to fund operations into 2029.
SEC filing